 |
|
April 30, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Abeona Therapeutics: FDA Approval of
Zevaskyn Accelerates Momentum and Expands
Treatment Options for the EB Community More
More
More*
More*
- Apertura Gene Therapy and Rett Syndrome
Research Trust: Collaborate to Pioneer
Advanced Genetic Medicines for Rett Syndrome
Using TfR1-Targeted AAV Capsid More
- Artios Pharma: Differentiated
Clinical Activity in STELLA Phase 1/2a Study
for Lead Program ART0380 at the American
Association for Cancer Research (AACR)
Annual Meeting 2025 More
More*
- Aspire Biopharma: Institutional Review Board
Approval for In-Human Clinical Trial of an
Oral Transmucosal Fast-Acting High-Dose
Aspirin Formulation More
- Feinstein Institutes: Artificial
Intelligence Identifies Brain Network
Predictive of Psychosis in Alzheimer’s Disease
More
- Inspira Health: Appoints New Officers to Its
Foundation Board
More
- Novo Nordisk: Expands Patient Access to
Authentic, FDA-Approved Wegovy via
Collaborations With Multiple Telehealth
Organizations More
- Tonix Pharmaceuticals: Preclinical Data on
Gastric Cancer Models at the American
Association for Cancer Research (AACR) 2025
Annual Meeting More
|
|
- Amarin: Regains Compliance
With Nasdaq Minimum Bid Price Requirement More
- BD: Board Declares Dividend More
- Mesoblast: Appendix 4c Quarterly Activity
Report for Quarter Ended March 31, 2025 More
- More on Merck Planning to Bring Keytruda
Production to the US With $1B Biologics
Factory More*
More*
More
- More on Pfizer, in Sweeping Cost
Cutting Push, Lifting Overall Savings Target
to $7.7B More
More
More*
More*
- More on Regeneron’s Eylea Franchise
Suffering Double Whammy With Sales Decline
and Surprise FDA Rejection More
More* More*
More*
- Protagenic Therapeutics: To Effect 1-for-14
Reverse Stock Split More
- Tevogen: Informs Public Shareholders About
DRS Accounts and Differences to Brokerage
Accounts More
- The Michael J. Fox Foundation: Expands
Landmark Parkinson’s Research Study Toward
Better Treatments and Prevention More
|
|
|
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems
More
- OPPORTUNITY: West Coast Business Development
Director
More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
